HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charcot as therapeutic interventionist and treating neurologist.

Abstract
Although Jean-Martin Charcot's best-known medical and scientific contributions relate to anatomical-clinical correlation, he was also a highly regarded physician. His published lectures and articles, as well as documents at the Bibliothèque Charcot, demonstrate his active interest in therapeutic interventions and in bringing new experimental treatments to France for study. He investigated the efficacy of bromides for epilepsy, colchicine for gout, and ergots and anticholinergic drugs for Parkinson's disease. Nonpharmacologic treatments in which he took interest included physical rehabilitation/speech therapy, hydrotherapy, electrical stimulation of weakened muscles, isolation, and exotic interventions such as suspension and vibratory treatments with special chairs and helmets. Letters from his patients reveal an active interchange, with patients complimenting Charcot on successful treatments but also demanding more effective ones when his prescriptions did not abate their conditions. These documents demonstrate that Charcot was not a therapeutic nihilist but was particularly active in therapeutic investigations in the context of 19th-century medical science.
AuthorsC G Goetz, M Bonduelle
JournalNeurology (Neurology) Vol. 45 Issue 11 Pg. 2102-6 (Nov 1995) ISSN: 0028-3878 [Print] United States
PMID7501168 (Publication Type: Biography, Historical Article, Journal Article)
Topics
  • France
  • History, 19th Century
  • Humans
  • Neurology (history)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: